Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07172607

The Effect of Avnace eZZe on Sleep Improvement

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
TCI Co., Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to examine the effectiveness of Avance eZZe drink with liposomal technology in improving sleep quality. Participants will be randomly assigned to either the placebo group, Avance eZZe drink group, and Avance eZZe drink without liposomal group, with 25 participants in each group. On the day of the experiment (day 0), participants are required to fill out questionnaires assessing sleep disorders and stress condition, and use a sleep monitoring system to track their sleep and autonomic nervous system conditions. Subsequently, participants will be given the experimental samples and instructed to consume them 1 hour before sleep daily for 28 days. Follow-up assessments will be conducted in the day-1, day-14 and day-28, participants are required to fill out questionnaires assessing sleep disorders and stress condition, and use a sleep monitoring system to track their sleep and autonomic nervous system conditions.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAvance eZZe drink25 mL liquid sachet, 1 sachet/day, consume 1 sachet of the sample 1 hour before sleep daily
DIETARY_SUPPLEMENTAvance eZZe drink (without liposomal)25 mL liquid sachet, 1 sachet/day, consume 1 sachet of the sample 1 hour before sleep daily
DIETARY_SUPPLEMENTPlacebo drink25 mL liquid sachet, 1 sachet/day, consume 1 sachet of the sample 1 hour before sleep daily

Timeline

Start date
2025-09-09
Primary completion
2026-04-30
Completion
2026-06-30
First posted
2025-09-15
Last updated
2026-02-04

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07172607. Inclusion in this directory is not an endorsement.